Ann Zilliox
Allergy & Immunology · Newport News, VANPI 1841284650
Payments from drug & device makers
Across 134 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$384
- Takeda Pharmaceuticals U.S.A., Inc.$256
- GSK$240
- Regeneron Healthcare Solutions, Inc.$166
- Sanofi$151
- Kaleo, Inc.$138
- plus $885 from 19 others
What the payments were for
- Food & beverage$2,220100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 24 | $384 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $256 |
| GSK | 16 | $240 |
| Regeneron Healthcare Solutions, Inc. | 11 | $166 |
| Sanofi | 9 | $151 |
| Kaleo, Inc. | 7 | $138 |
| AstraZeneca | 7 | $107 |
| Pfizer | 4 | $105 |
| Pharming Healthcare, Inc. | 6 | $104 |
| Teva Pharmaceuticals USA, Inc. | 6 | $103 |
| Biocryst US Sales Co., LLC | 5 | $77 |
| Genentech USA, Inc. | 4 | $59 |
| Incyte Corporation | 2 | $45 |
| Novartis | 3 | $44 |
| Phadia US Inc. | 2 | $39 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Boehringer Ingelheim | 2 | $28 |
| Boston Scientific | 1 | $25 |
| Shire North American Group Inc | 2 | $25 |
| Biocryst Pharmaceuticals, Inc. | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Merck | 1 | $15 |
| Bio Products Laboratory USA, Inc. | 1 | $12 |
| Greer Laboratories, Inc. | 1 | $12 |
| Alk-abello, Inc | 1 | $11 |
How this compares
$2,220 in reported general payments places this provider in the 40th percentile of 133 allergy & immunology providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 22 | $8,485 |
| Ipratropium Bromide | 15 | $962 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta | $240 | $8,48522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 133 allergy & immunology providers in Virginia.
Other allergy & immunology in Newport News
- Larry BorishCharlottesville$2.3M
- Charles LaneLynchburg$1.4M
- Jacqueline Eghrari-SabetVienna$1.1M
- Eric KarlinWilliamsburg$603K
- Nicholas RiderRoanoke$381K
- Oral AlpanSpringfield$193K
- Courtney BlairMc Lean$139K
- Emily McGowanCharlottesville$137K
- Andrew KimFredericksburg$104K
- Behnam DaghighLeesburg$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.